Search

Abbott Laboratories

Lezárt

SzektorEgészségügy

102.98 0.45

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

101.62

Maximum

103.17

Fő mutatók

By Trading Economics

Bevétel

-149M

928M

Értékesítés

1.4B

13B

P/E

Szektor átlag

33.363

56.432

Egy részvényre jutó nyereség

1.31

Osztalékhozam

2.43

Profit margin

7.369

Munkavállalók

122,000

EBITDA

-465M

1.8B

Ajánlások

By TipRanks

Ajánlások

Erős vétel

12 hónapos előrejelzés

+21.17% upside

Osztalékok

By Acuity

Osztalékhozam

Szektor átlag

2.43%

2.27%

Következő eredményjelentés

2026. okt. 14.

Következő osztalékfizetési dátum

2026. nov. 16.

Következő korábbi osztalék dátum

2026. okt. 15.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

16B

180B

Előző nyitás

102.53

Előző zárás

102.98

Hangulat hírek alapján

By Acuity

39%

61%

81 / 339 Rangsor szerint Healthcare

Abbott Laboratories Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. szept. 21. 23:00 UTC

Abbott Laboratories is trading modestly higher in after-market hours, recovering from earlier declines but remains below its 20-day moving average.

2026. szept. 16. 19:16 UTC

Abbott Laboratories shares are modestly higher but remain below their 20-day moving average and near the lower end of their one-month range.

2026. szept. 15. 23:01 UTC

Abbott Laboratories shares are higher in after-market hours, reflecting broader market trends. No specific company news was identified to explain the movement.

2026. szept. 14. 22:51 UTC

Abbott Laboratories shares are lower in after-market hours, reflecting broader market declines amid rising crude oil prices due to geopolitical supply concerns.

2026. szept. 12. 00:01 UTC

Abbott Laboratories shares are higher in after-market trading, despite being below the 20-day moving average and a trend of lower closes.

2026. szept. 11. 23:01 UTC

Abbott Laboratories shares are higher in after-market trading, settling at a cumulative return of 1.60%. The U.S. budget deficit for August was $167 billion.

2026. szept. 10. 19:16 UTC

News

Abbott Laboratories received FDA approval for its TactiFlex Duo catheter. Shares are lower today, continuing a trend of declining prices over the past week.

2026. szept. 9. 23:26 UTC

News

Abbott Laboratories received U.S. FDA approval for its TactiFlex Duo ablation catheter. Shares are higher in after-market trading, reflecting a recovery from recent declines.

2026. szept. 8. 20:02 UTC

News

Abbott Laboratories shares are lower, reaching a four-week low of $106.72 amid weakness in the Health Care Equipment sector despite FDA approval for its ablation catheter.

2026. szept. 4. 20:07 UTC

Abbott Laboratories shares are lower, influenced by a strong jobs report that increased selling pressure across risk assets. The stock remains near its one-month trading range low.

2026. szept. 3. 23:31 UTC

Abbott Laboratories shares declined in after-market trading, reflecting ongoing weakness. The stock is near the lower end of its one-month range.

2026. szept. 2. 23:56 UTC

Abbott Laboratories shares are lower in after-market hours, reflecting a decline since Wednesday's close amid weaker-than-expected job growth reported by ADP.

2026. szept. 1. 23:51 UTC

Abbott Laboratories shares are higher in after-market hours amid notable trading activity. Rising oil prices and inflation concerns may influence Federal Reserve policy decisions.

2026. aug. 31. 23:32 UTC

Correlated Moves

Abbott Laboratories sees gains in after-market trading, reflecting strength in the health care equipment sector and broader positive trends among correlated assets.

2026. aug. 28. 23:16 UTC

Correlated Moves

Abbott Laboratories shares are higher in after-market hours, following a modest gain earlier, alongside Medtronic PLC's advance in the health care equipment sector.

2026. aug. 27. 22:51 UTC

Abbott Laboratories shares are trading higher in after-market hours, reversing three consecutive daily declines. No specific news was identified to explain the movement.

2026. aug. 26. 23:21 UTC

Abbott Laboratories is higher in after-market hours, reflecting broader market gains. The stock remains above its 20-day moving average despite recent fluctuations.

2026. aug. 25. 23:26 UTC

Abbott Laboratories shares declined after-market, with no specific news identified. Broader market sentiment was affected by falling crude oil prices amid eased geopolitical tensions.

2026. aug. 24. 23:01 UTC

Abbott Laboratories shares are trading lower in after-market hours. Broader market weakness and geopolitical tensions are contributing to the price movement.

2026. aug. 21. 23:01 UTC

Abbott Laboratories shares were lower in after-market trading, despite being above the 20-day moving average and near the upper end of their one-month range.

2026. aug. 20. 23:01 UTC

News

Abbott Laboratories settles litigation for $670 million over preterm infant formulas, trading lower in after-market hours following the news.

2026. aug. 19. 23:01 UTC

Abbott Laboratories shares are lower in after-market hours following a volatile session, despite trading above their 20-day moving average. No specific news was identified.

2026. aug. 18. 23:16 UTC

Shares of Abbott Laboratories are higher in after-market trading, remaining above the 20-day moving average and near the upper end of the one-month range.

2026. aug. 17. 23:41 UTC

Abbott Laboratories shares are trading lower in after-market hours. Broader market volatility is linked to rising crude oil prices and geopolitical tensions.

2026. aug. 14. 23:02 UTC

Abbott Laboratories shares are trading higher in after-market hours, showing strength above the 20-day moving average despite mixed market sentiment and declining U.S. retail sales.

2026. aug. 13. 23:01 UTC

Abbott Laboratories shares are lower in after-market trading, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

2026. aug. 12. 23:46 UTC

Abbott Laboratories shares are lower in after-market trading, with no specific news identified for the decline. Broader market optimism follows recent inflation data.

2026. aug. 11. 19:16 UTC

News

Abbott Laboratories announced a partnership with Google Health to enhance glucose management through AI. Shares are trading higher amid positive market sentiment.

2026. aug. 10. 23:46 UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified for the decline. The stock remains above its 20-day moving average.

2026. aug. 7. 23:06 UTC

Abbott Laboratories shares declined slightly in after-market trading. The stock remains above its 20-day moving average and near the upper end of its one-month range.

Társak összehasonlítása

Árváltozás

Abbott Laboratories Előrejelzés

Célár

By TipRanks

21.17% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 124.333 USD  21.17%

Magas 135 USD

Alacsony 112 USD

15 Wall Street elemző 12 hónapos célárain alapulva a(z)Abbott Laboratories termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

15 ratings

15

Vétel

0

Tartás

0

Eladás

Hangulat

By Acuity

81 / 339 Rangsor szerint Egészségügy

Hangulat hírek alapján

Bullish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag alatti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.